US FDA Asks Prostate Ablation Device-Sponsors For More Clinical Safety Data To Support Clearances
Executive Summary
Almost four years after the agency first authorized a prostate ablation device, regulators have proposed a number of requirements for clinical studies that sponsors would have to meet to comply with special controls needed for the devices to be cleared for marketing.